SCHEMBL13487409

SCHEMBL13487409

O=C1C(=O)c2cc(F)ccc2-c2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 10/20 0.60
PTPN1 P18031 4/20 0.60
S100A4 P26447 4/20 0.59
NPC1 O15118 4/20 0.59
RAB9A P51151 4/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
APAF1 O14727 3/20 0.59
LMNA P02545 3/20 0.59
HTT P42858 3/20 0.59
GALK1 P51570 3/20 0.59
BLM P54132 3/20 0.59
NPSR1 Q6W5P4 3/20 0.59
TDP2 O95551 2/20 0.59
PLA2G1B P04054 2/20 0.59
POLB P06746 2/20 0.59
PLCG1 P19174 2/20 0.59
PPARG P37231 2/20 0.59
ATG4B Q9Y4P1 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30886642 1.00 PTPRC (0.60) PTPRCPTPN1S100A4NPC1RAB9A
SCHEMBL181722 0.95 PTPRC (0.55) PTPRCPTPN1S100A4NPC1RAB9A
SCHEMBL29390818 0.95 PTPRC (0.55) PTPRCPTPN1S100A4NPC1RAB9A
SCHEMBL13487417 0.95 PTPRC (0.59) PTPRCPTPN1S100A4NPC1RAB9A
SCHEMBL3894758 0.93 MEN1 (0.57) PTPRCPTPN1S100A4NPC1RAB9A
SCHEMBL563010 0.91 MEN1 (0.55) PTPRCPTPN1S100A4NPC1RAB9A
SCHEMBL9811010 0.86 CA1 (0.48) PTPRCPTPN1S100A4NPC1RAB9A
SCHEMBL13487415 0.85 CA1 (0.52) PTPRCPTPN1S100A4NPC1RAB9A
SCHEMBL30479662 0.85 CA1 (0.52) PTPRCPTPN1S100A4MAOAALDH1A1
SCHEMBL7432075 0.85 CA1 (0.52) PTPRCPTPN1S100A4MAOAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117940431-A Compound, light-emitting material, and light-emitting element 九州有机光材股份有限公司 2024-04-26 CN disclosed
EP-2128121-B1 ELECTRODE ACTIVE MATERIAL COMPRISING A PHENANTHRENEQUINONE COMPOUND AND ELECTRICAL STORAGE DEVICE INCLUDING THE SAME PANASONIC CORP (JP) 2013-09-11 EP disclosed
US-8338027-B2 Phenanthrenequinone compound, electrode active material, and power storage device PANASONIC CORPORATION (JP) 2012-12-25 US disclosed
US-8338027-B2 Phenanthrenequinone compound, electrode active material, and power storage device PANASONIC CORPORATION (JP) 2012-12-25 US disclosed
US-20100047688-A1 PHENANTHRENEQUINONE COMPOUND, ELECTRODE ACTIVE MATERIAL, AND POWER STORAGE DEVICE PANASONIC CORPORATION (JP) 2010-02-25 US disclosed
US-20100047688-A1 PHENANTHRENEQUINONE COMPOUND, ELECTRODE ACTIVE MATERIAL, AND POWER STORAGE DEVICE PANASONIC CORPORATION (JP) 2010-02-25 US disclosed
EP-2128121-A1 PHENANTHRENEQUINONE COMPOUND, ELECTRODE ACTIVE MATERIAL, AND ELECTRICAL STORAGE DEVICE Panasonic Corporation (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100047688-A1 PHENANTHRENEQUINONE COMPOUND, ELECTRODE ACTIVE MATERIAL, AND POWER STORAGE DEVICE RECQL, POLQ, COQ8A PTPRC 2718/4885PTPN1 4133/4885S100A4 3966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.